| |
 |
|
 |
| |
Minerva
Biolabs: Minerva Biolabs GmbH started with innovative
products for the effective diagnosis and elimination of Mycoplasma
contamination in cell cultures and biopharmaceuticals. Minerva
Biolabs leads the market in PCR based detection of Mycoplasma
and further elimination and prevention of this contamination.
Mycoplasma contamination in cell cultures can have several unidentified
effects on the reproducibility of results and can cause substantial
economic damage during production of biopharmaceuticals/vaccines.
|
 |
|
|
|